Have a personal or library account? Click to login
Therapeutic Management in Ulcerative Colitis Cover

Therapeutic Management in Ulcerative Colitis

By: Roxana Călin and  Petruţ Nuţă  
Open Access
|Mar 2019

References

  1. 1. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders, Journal of Crohn’s and Colitis, Volume 11, Issue 6, 1 June 2017, Pages 649–670)10.1093/ecco-jcc/jjx008
  2. 2. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management, Journal of Crohn’s and Colitis (2012) 6, 991–103010.1016/j.crohns.2012.09.002
  3. 3. Christian Maaser at all, ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications, Journal of Crohn’s and Colitis, Volume 13, Issue 2, 1 February 2019, Pages 144–164K10.1093/ecco-jcc/jjy113
  4. 4. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955;2:1041–8.10.1136/bmj.2.4947.1041
  5. 5. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19:5A–36A10.1155/2005/269076
  6. 6. Orlando A. et all. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factoralpha antagonist therapy in inflammatory bowel disease.Dig LiverDis. 2011;43:1-20.10.1016/j.dld.2010.07.010
  7. 7. Danese S. et all. Causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy. Aliment Pharmacol Ther. 2011;34:1-1010.1111/j.1365-2036.2011.04679.x
  8. 8. Imdad A, Nicholson MR, Tanner-Smith EE, Zackular JP, Gomez-Duarte OG, Beaulieu DB, Acra S. Fecal transplantation for treatment of inflammatory bowel disease. Cochrane Database of Systematic Reviews 2018, Issue 11. Art. No.: CD01277410.1002/14651858.CD012774.pub2
  9. 9. Ingrid Ordás et al, Ulcerative colitis, The Lancet, Volume 380, Issue 9853, 1606 – 16110.1016/S0140-6736(12)60150-0
  10. 10. Sleisenger and Fordtran’s, Gastrointestinal and liver disease, Saunders, Elsevier 2010
  11. 11. American College of Gastroenterology, Ulcerative Colitis in Adults,AmJ Gastroenterol 2010; 105:501–52310.1038/ajg.2009.72720068560
  12. 12. Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus, Gastroenterology 2015; 148:1035–105810.1053/j.gastro.2015.03.001
  13. 13. D’Haens G, SandbornWJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007;132:763–8610.1053/j.gastro.2006.12.03817258735
DOI: https://doi.org/10.2478/inmed-2018-0047 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 61 - 72
Published on: Mar 28, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Roxana Călin, Petruţ Nuţă, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.